HUMAN ADENOVIRUS B SEROTYPE 21
UNII 52LF3Q0M9V

Substance Identification & Data

This profile provides standardized clinical and technical data for Human Adenovirus B Serotype 21, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 52LF3Q0M9V.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
52LF3Q0M9V
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
HUMAN ADENOVIRUS B SEROTYPE 21
Official standardized name for this substance within the FDA UNII nomenclature system.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
NCBI Taxonomy
32608
Unique numeric identifier used to specify biological species in the NCBI database.

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Human Adenovirus B Serotype 21. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

HUMAN ADENOVIRUS B SEROTYPE 21

Systematic Nomenclature

MASTADENOVIRUS: HUMAN MASTADENOVIRUS B SEROTYPE 21
MASTADENOVIRUS: HUMAN MASTADENOVIRUS B SEROTYPE 21 WHOLE

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record